Marinus Pharmaceuticals reported $-19169000 in Operating Profit for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Acadia Pharmaceuticals ACAD:US $ -15.3M 28.41M
Adamas Pharmaceuticals ADMS:US -5636000 3.52M
ALKERMES ALKS:US -19659000 24.08M
Amgen AMGN:US $ 2378M 1550M
Aptinyx Inc APTX:US $ -21206000 1.34M
Arena Pharmaceuticals ARNA:US $ -194.48M 50.09M
Biogen BIIB:US $ 794M 308.3M
Eisai 4523:JP Y 5499M 49908M
Enanta Pharmaceuticals ENTA:US $ -33.73M 0.12M
Esperion Therapeutics ESPR:US $ -55745000 23.21M
Gilead Sciences GILD:US $ 3842M 1596M
Intercept Pharmaceuticals ICPT:US $ 10.29M 9.53M
Intra Cellular Therapies ITCI:US $ -77.32M 8.18M
Marinus Pharmaceuticals MRNS:US $ -19.17M 4.32M
Minerva Neurosciences NERV:US $ -7.52M 1.44M
Neurocrine Biosciences NBIX:US $ 44.5M 18.3M
Ptc Therapeutics PTCT:US $ -93.08M 5.42M
Regeneron Pharmaceuticals REGN:US $ 1847.2M 1500M
Sarepta Therapeutics SRPT:US $ -38.95M 128.63M
Supernus Pharmaceuticals SUPN:US $ 32.6M 1.51M
Vertex Pharmaceuticals VRTX:US $ 1054.51M 1092.47M
YTE INCY:US $ 235.41M 94.57M
Zogenix ZGNX:US $ -53.87M 1.56M